| Phone Icon 403.210.5275 | Email Icon Contact Us | Resize Text
  • New investments drive cutting-edge R&D in health in Alberta

    Genome Canada announces $6M investment for enhancing early-warning systems to promote public health and $2.88M for improving the treatment of autoimmune diseases.

  • Blog Icon

    New investments drive cutting-edge R&D in health in Alberta

    Genome Canada announces $6M investment for enhancing early-warning systems to promote public health and $2.88M for improving the treatment of autoimmune diseases.